BIVI
4:01 PM
BioVie to Host Conference Call to Discuss Topline Data from Phase 2 ADDRESS-LC Trial and the Potential of Bezisterim in Long Covid
Results Call • Phase 2bioviepharma.com
Catalyst Calendar
Mon, Sep 14, 2026
1 updatesThu, Aug 6, 2026
1 updatesBIVI
7:30 AM
BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease
Trial Results • Phase 2bioviepharma.com